Preparation of pH-Responsive Vesicular Deferasirox: Evidence from In Silico, In Vitro, and In Vivo Evaluations

[Image: see text] pH-sensitive nanocarriers can effectively deliver anticancer drugs to tumors and reduce the adverse effects of conventional chemotherapy. In this light, we prepared a novel pH-responsive deferasirox (DFX)-loaded vesicle and comprehensively performed in silico, in vitro, and in vivo...

Descripción completa

Detalles Bibliográficos
Autores principales: Barani, Mahmood, Sargazi, Saman, Hajinezhad, Mohammad Reza, Rahdar, Abbas, Sabir, Fakhara, Pardakhty, Abbas, Zargari, Farshid, Anwer, Md. Khalid, Aboudzadeh, M. Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459436/
https://www.ncbi.nlm.nih.gov/pubmed/34568700
http://dx.doi.org/10.1021/acsomega.1c03816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459436/
https://www.ncbi.nlm.nih.gov/pubmed/34568700
http://dx.doi.org/10.1021/acsomega.1c03816

Ejemplares similares